EUVIMEDEUVIMED entdecken
Crossref

Lung transplant for CF: Low lung bacterial burden and immune mediators in year one associate with CLAD development

Samantha A Whiteside, John E McGinniss, Rebecca A Deek, Carter Merenstein, Noel Britton, Aurea Simon-Soro, Michelle Oyster, Laurel Kalman, Melanie C Brown, Jevon Graham-Wooten, John F McDyer, Pali Shah und 8 weitere

Journal of Cystic Fibrosis · 2026-01 · 25 (1) · 52-62

DOI: 10.1016/j.jcf.2025.10.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cystic Fibrosis, 2026-01. Verfasst von Samantha A Whiteside und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Allergy and Critical Care, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, America. Hauptthemen laut MEDLINE: Cystic Fibrosis, Lung Transplantation, Lung, Primary Graft Dysfunction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Cystic Fibrosis Foundation, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Lung transplantation is commonly required for advanced lung disease in cystic fibrosis (CF). Long-term lung allograft survival is limited primarily by chronic lung allograft dysfunction (CLAD), and microbial factors have been implicated in CLAD development. However studies have not specifically investigated CF patients despite the unique microbe-rich nature of the CF respiratory tract. We investigated whether early post-transplantation lung microbiome features associate with CLAD development. METHODS: We investigated a longitudinal cohort of 23 CF patients undergoing lung transplantation. Lung lavage was collected from donor lungs, and from recipient allografts serially during the first year post-transplantation. Patients were followed for a median of 4.9 years. This was complemented by a case-control study of 8 CF patients sampled at incident CLAD along with non-CLAD CF transplant controls. Lung bacteria were enumerated by 16S rRNA gene sequencing and quantified by qPCR, and immune mediators investigated by multiplex assay. RESULTS: Cohort patients who developed CLAD had lower lung bacterial burden, lower relative abundances of classic CF lung microbiota, and lower mediator levels during the first-year post-transplantation than those remaining CLAD-free. In contrast, incident CLAD showed elevated lung immune mediators but no microbiome differences. CONCLUSIONS: Low lung bacterial content and immune mediators during the first year post-transplantation for CF associate CLAD, whereas CLAD onset is characterized by elevated immune mediators but no lung microbiome differences. Whether airway bacteria early after transplantation for CF may protect against CLAD or serve as a biomarker merits further study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisLung TransplantationLungPrimary Graft DysfunctionHumansMaleFemaleLongitudinal StudiesBacterial LoadAdultAdolescentChildMicrobiotaCase-Control StudiesGraft SurvivalYoung Adult

Stichwörter der Autor:innen

Chronic allograft dysfunctionCystic fibrosisLung microbiomeLung transplantation

Autor:innen und Institutionen

  • Division of Pulmonary, Allergy and Critical Care, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, America.
  • Department of Epidemiology, Biostatistics and Informatics, University of Pennsylvania School of Medicine, Philadelphia, PA, America.
  • Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, PA, America.
  • Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, America.
  • Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, America.
  • Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia, PA, America.

Förderung

  • Cystic Fibrosis Foundation
  • National Institutes of Health

Zitieren

APA

Whiteside, S. A., McGinniss, J. E., Deek, R. A., Merenstein, C., Britton, N., Simon-Soro, A., Oyster, M., Kalman, L., Brown, M. C., Graham-Wooten, J., McDyer, J. F., Shah, P., D'Alessio, F., Cantu, E., Clausen, E. S., Li, H., Diamond, J. M., Bushman, F. D., Christie, J. D., & Collman, R. G. (2026). Lung transplant for CF: Low lung bacterial burden and immune mediators in year one associate with CLAD development. Journal of Cystic Fibrosis, 25(1), 52-62. https://doi.org/10.1016/j.jcf.2025.10.002

Vancouver

Whiteside SA, McGinniss JE, Deek RA, Merenstein C, Britton N, Simon-Soro A, et al. Lung transplant for CF: Low lung bacterial burden and immune mediators in year one associate with CLAD development. Journal of Cystic Fibrosis. 2026;25(1):52-62. doi:10.1016/j.jcf.2025.10.002

BibTeX
@article{Whiteside2026,
  author = {Whiteside, Samantha A and McGinniss, John E and Deek, Rebecca A and Merenstein, Carter and Britton, Noel and Simon-Soro, Aurea and Oyster, Michelle and Kalman, Laurel and Brown, Melanie C and Graham-Wooten, Jevon and McDyer, John F and Shah, Pali and D'Alessio, Franco and Cantu, Edward and Clausen, Emily S and Li, Hongzhe and Diamond, Joshua M and Bushman, Frederic D and Christie, Jason D and Collman, Ronald G},
  title = {Lung transplant for CF: Low lung bacterial burden and immune mediators in year one associate with CLAD development},
  journal = {Journal of Cystic Fibrosis},
  year = {2026},
  volume = {25},
  number = {1},
  pages = {52--62},
  doi = {10.1016/j.jcf.2025.10.002}
}
Kostenlos starten →